Letter to the editor regarding 'Estetrol (E4): the new estrogenic component of combined oral contraceptives'
- PMID: 32981383
- DOI: 10.1080/17512433.2020.1828544
Letter to the editor regarding 'Estetrol (E4): the new estrogenic component of combined oral contraceptives'
Comment on
-
Estetrol (E4): the new estrogenic component of combined oral contraceptives.Expert Rev Clin Pharmacol. 2020 Apr;13(4):327-330. doi: 10.1080/17512433.2020.1750365. Epub 2020 Apr 7. Expert Rev Clin Pharmacol. 2020. PMID: 32238069 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources